Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership516,996 shares
Latest Disclosed Value $ 2,326,482
Squarepoint Ops LLC reports 50.40% increase in ownership of MYGN / Myriad Genetics, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 516,996 shares of Myriad Genetics, Inc. (US:MYGN) valued at $2,326,482 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 343,743 shares of Myriad Genetics, Inc.. This represents a change in shares of 50.40% during the quarter. The current value of the position is $2,274,782 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MYRIAD GENETICS COM 62855J104 516,996 173,253 50.40 2,326 10.03 0.0027
2026-02-13 2025-12-31 13F MYRIAD GENETICS COM 62855J104 343,743 225,436 190.55 2,114 147.25 0.0022
2025-11-14 2025-09-30 13F MYRIAD GENETICS COM 62855J104 118,307 -30,028 -20.24 855 8.64 0.0009
2025-08-27 2025-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 148,335 68,208 85.12 788 10.85 0.0008
2025-08-14 2025-06-30 13F MYRIAD GENETICS COM 62855J104 148,335 68,208 788 0.0008
2025-08-27 2025-03-31 13F/A-1 MYRIAD GENETICS COM 62855J104 80,127 -58,742 -42.30 711 -62.69 0.0009
2025-05-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 80,127 -58,742 711 0.0009
2025-02-14 2024-12-31 13F MYRIAD GENETICS COM 62855J104 138,869 29,524 27.00 1,904 -36.44 0.0019
2024-11-14 2024-09-30 13F MYRIAD GENETICS COM 62855J104 109,345 82,059 300.74 2,995 348.88 0.0047
2024-08-14 2024-06-30 13F MYRIAD GENETICS COM 62855J104 27,286 -59,290 -68.48 667 -63.85 0.0011
2024-05-15 2024-03-31 13F MYRIAD GENETICS COM 62855J104 86,576 45,572 111.14 1,846 135.33 0.0032
2024-02-14 2023-12-31 13F MYRIAD GENETICS COM 62855J104 41,004 16,265 65.75 785 97.98 0.0015
2023-11-14 2023-09-30 13F MYRIAD GENETICS COM 62855J104 24,739 9,598 63.39 397 13.14 0.0010
2023-08-14 2023-06-30 13F MYRIAD GENETICS COM 62855J104 15,141 -11,518 -43.20 351 -43.46 0.0011
2023-05-15 2023-03-31 13F MYRIAD GENETICS COM 62855J104 26,659 -139,725 -83.98 619 -74.36 0.0025
2023-02-14 2022-12-31 13F MYRIAD GENETICS COM 62855J104 166,384 140,496 542.71 2,414 388.66 0.0095
2022-11-14 2022-09-30 13F MYRIAD GENETICS COM 62855J104 25,888 25,888 494 0.0025
2021-02-16 2020-12-31 13F MYRIAD GENETICS COM 62855J104 0 -35,862 -100.00 0 -100.00
2020-11-16 2020-09-30 13F MYRIAD GENETICS COM 62855J104 35,862 -51,191 -58.80 468 -52.58 0.0063
2020-08-14 2020-06-30 13F MYRIAD GENETICS COM 62855J104 87,053 87,053 987 0.0160
2020-02-14 2019-12-31 13F MYRIAD GENETICS COM 62855J104 0 -7,700 -100.00 0 -100.00
2019-11-14 2019-09-30 13F MYRIAD GENETICS COM 62855J104 7,700 -65,938 -89.54 220 -89.25 0.0020
2019-08-14 2019-06-30 13F MYRIAD GENETICS COM 62855J104 73,638 73,638 2,046 0.0199
2019-05-15 2019-03-31 13F MYRIAD GENETICS COM 62855J104 0 -19,235 -100.00 0 -100.00
2019-02-14 2018-12-31 13F MYRIAD GENETICS COM 62855J104 19,235 2,596 15.60 559 -26.93 0.0065
2018-11-14 2018-09-30 13F MYRIAD GENETICS COM 62855J104 16,639 16,639 765 0.0092
2018-08-14 2018-06-30 13F MYRIAD GENETICS COM 62855J104 0 -42,560 -100.00 0 -100.00
2018-05-15 2018-03-31 13F MYRIAD GENETICS COM 62855J104 42,560 17,544 70.13 1,258 46.45 0.0200
2018-02-14 2017-12-31 13F MYRIAD GENETICS COM 62855J104 25,016 -27,316 -52.20 859 -54.62 0.0150
2017-11-14 2017-09-30 13F MYRIAD GENETICS COM 62855J104 52,332 -2,919 -5.28 1,893 32.56 0.0364
2017-08-14 2017-06-30 13F MYRIAD GENETICS COM 62855J104 55,251 55,251 1,428 0.0281
2017-05-15 2017-03-31 13F MYRIAD GENETICS COM 62855J104 0 -44,638 -100.00 0 -100.00
2017-02-14 2016-12-31 13F MYRIAD GENETICS COM 62855J104 44,638 44,638 0.00 744 0.0304
2016-11-14 2016-09-30 13F MYRIAD GENETICS COM 62855J104 0 -13,680 -100.00 0 -100.00
2016-08-15 2016-06-30 13F MYRIAD GENETICS COM 62855J104 13,680 -7,420 -35.17 419 -46.96 0.0261
2016-05-16 2016-03-31 13F MYRIAD GENETICS COM 62855J104 21,100 14,300 210.29 790 169.62 0.0612
2016-02-16 2015-12-31 13F MYRIAD GENETICS COM 62855J104 6,800 6,800 293 0.0321
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.